Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guadalupe Mengod

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Cerebral Cortex (New York, N.Y. : 1991)|February 3, 2004
Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortexMercè Amargós-Bosch, Analía Bortolozzi, M Victoria Puig, et al.
The European Journal of Neuroscience|August 26, 2018
Comparative study of the expression of cholinergic system components in the CNS of experimental autoimmune encephalomyelitis mice: Acute vs remitting phaseGiovanni Di Pinto, Maria Di Bari, Rocío Martin-Alvarez, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 3, 2004
Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's diseaseJosep M Canals, José R Pineda, Jesús F Torres-Peraza, et al.
Neuropharmacology|March 15, 2017
Galanin (1-15) enhancement of the behavioral effects of Fluoxetine in the forced swimming test gives a new therapeutic strategy against depressionAntonio Flores-Burgess, Carmelo Millón, Belén Gago, et al.
Journal of Medicinal Chemistry|January 5, 2002
New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanonesJosé Brea, Jordi Rodrigo, Antonio Carrieri, et al.
ACS Chemical Neuroscience|October 19, 2012
Identification in silico and experimental validation of novel phosphodiesterase 7 inhibitors with efficacy in experimental autoimmune encephalomyelitis miceMiriam Redondo, Valle Palomo, José Brea, et al.
Molecular Pharmacology|March 13, 2009
Evidence for distinct antagonist-revealed functional states of 5-hydroxytryptamine(2A) receptor homodimersJosé Brea, Marián Castro, Jesús Giraldo, et al.
The Journal of Comparative Neurology|December 2, 2009
Ikaros-1 couples cell cycle arrest of late striatal precursors with neurogenesis of enkephalinergic neuronsRaquel Martín-Ibáñez, Empar Crespo, Noelia Urbán, et al.
Journal of Medicinal Chemistry|March 6, 2012
Effect of phosphodiesterase 7 (PDE7) inhibitors in experimental autoimmune encephalomyelitis mice. Discovery of a new chemically diverse family of compoundsMiriam Redondo, José Brea, Daniel I Perez, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 6, 2021
Identification of BiP as a CB<sub>1</sub> Receptor-Interacting Protein That Fine-Tunes Cannabinoid Signaling in the Mouse BrainCarlos Costas-Insua, Estefanía Moreno, Irene B Maroto, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Cerebral Cortex (New York, N.Y. : 1991)|February 3, 2004
Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortexMercè Amargós-Bosch, Analía Bortolozzi, M Victoria Puig, et al.
The European Journal of Neuroscience|August 26, 2018
Comparative study of the expression of cholinergic system components in the CNS of experimental autoimmune encephalomyelitis mice: Acute vs remitting phaseGiovanni Di Pinto, Maria Di Bari, Rocío Martin-Alvarez, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 3, 2004
Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's diseaseJosep M Canals, José R Pineda, Jesús F Torres-Peraza, et al.
Neuropharmacology|March 15, 2017
Galanin (1-15) enhancement of the behavioral effects of Fluoxetine in the forced swimming test gives a new therapeutic strategy against depressionAntonio Flores-Burgess, Carmelo Millón, Belén Gago, et al.
Journal of Medicinal Chemistry|January 5, 2002
New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanonesJosé Brea, Jordi Rodrigo, Antonio Carrieri, et al.
ACS Chemical Neuroscience|October 19, 2012
Identification in silico and experimental validation of novel phosphodiesterase 7 inhibitors with efficacy in experimental autoimmune encephalomyelitis miceMiriam Redondo, Valle Palomo, José Brea, et al.
Molecular Pharmacology|March 13, 2009
Evidence for distinct antagonist-revealed functional states of 5-hydroxytryptamine(2A) receptor homodimersJosé Brea, Marián Castro, Jesús Giraldo, et al.
The Journal of Comparative Neurology|December 2, 2009
Ikaros-1 couples cell cycle arrest of late striatal precursors with neurogenesis of enkephalinergic neuronsRaquel Martín-Ibáñez, Empar Crespo, Noelia Urbán, et al.
Journal of Medicinal Chemistry|March 6, 2012
Effect of phosphodiesterase 7 (PDE7) inhibitors in experimental autoimmune encephalomyelitis mice. Discovery of a new chemically diverse family of compoundsMiriam Redondo, José Brea, Daniel I Perez, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 6, 2021
Identification of BiP as a CB<sub>1</sub> Receptor-Interacting Protein That Fine-Tunes Cannabinoid Signaling in the Mouse BrainCarlos Costas-Insua, Estefanía Moreno, Irene B Maroto, et al.
Pageof 5